FUJIFILM Holdings Corporation (TYO:4901)
Japan flag Japan · Delayed Price · Currency is JPY
3,284.00
-12.00 (-0.36%)
May 30, 2025, 3:30 PM JST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2012 - 2020
Imaging
541.97B
Log In
Log In
Log In
Log In
Upgrade
Imaging Growth
15.40%
Log In
Log In
Log In
Log In
Upgrade
Healthcare
1,022.56B
Log In
Log In
Log In
Log In
Upgrade
Healthcare Growth
4.87%
Log In
Log In
Log In
Log In
Upgrade
Electronics
-
Log In
Log In
Log In
Log In
Upgrade
Electronics Growth
-
Log In
Log In
Log In
Log In
Upgrade
Business Innovation
-
Log In
Log In
Log In
Log In
Upgrade
Business Innovation Growth
-
Log In
Log In
Log In
Log In
Upgrade
Electronics Revenue (Post-Q3 2024 Reporting)
432.80B
Log In
Log In
Log In
Log In
Upgrade
Business Innovation Revenue (Post-Q3 2024 Reporting)
1,198.49B
Log In
Log In
Log In
Log In
Upgrade

Capex by Product

Fiscal year is April - March.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2012 - 2020
Imaging Capital Expenditures
21.60B
Log In
Log In
Log In
Log In
Upgrade
Imaging Capital Expenditures Growth
-
Log In
Log In
Log In
Log In
Upgrade
Corporate Capital Expenditures
6.38B
Log In
Log In
Log In
Log In
Upgrade
Corporate Capital Expenditures Growth
-
Log In
Log In
Log In
Log In
Upgrade
Healthcare Capital Expenditures
464.91B
Log In
Log In
Log In
Log In
Upgrade
Healthcare Capital Expenditures Growth
-
Log In
Log In
Log In
Log In
Upgrade
Electronics Capital Expenditures
-
Log In
Log In
Log In
Log In
Upgrade
Electronics Capital Expenditures Growth
-
Log In
Log In
Log In
Log In
Upgrade
Business Innovation Capital Expenditures
-
Log In
Log In
Log In
Log In
Upgrade
Business Innovation Capital Expenditures Growth
-
Log In
Log In
Log In
Log In
Upgrade
Electronics Capital Expenditures (Post-Q3 2024 Reporting)
41.26B
Log In
Log In
Log In
Log In
Upgrade
Business Innovation Capital Expenditures (Post-Q3 2024 Reporting)
73.04B
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is April - March.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2012 - 2020
Imaging Operating Income
139.21B
Log In
Log In
Log In
Log In
Upgrade
Imaging Operating Income Growth
36.44%
Log In
Log In
Log In
Log In
Upgrade
Corporate Operating Income
-38.62B
Log In
Log In
Log In
Log In
Upgrade
Corporate Operating Income Growth
5.92%
Log In
Log In
Log In
Log In
Upgrade
Healthcare Operating Income
77.64B
Log In
Log In
Log In
Log In
Upgrade
Healthcare Operating Income Growth
-20.28%
Log In
Log In
Log In
Log In
Upgrade
Electronics Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Electronics Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade
Business Innovation Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Business Innovation Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade
Electronics Operating Income (Post-Q3 2024 Reporting)
77.32B
Log In
Log In
Log In
Log In
Upgrade
Business Innovation Operating Income (Post-Q3 2024 Reporting)
74.61B
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2012 - 2020
Domestic
1,099.30B
Log In
Log In
Log In
Log In
Upgrade
Domestic Growth
4.74%
Log In
Log In
Log In
Log In
Upgrade
The Americas
646.90B
Log In
Log In
Log In
Log In
Upgrade
The Americas Growth
0.80%
Log In
Log In
Log In
Log In
Upgrade
Europe
544.63B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
15.74%
Log In
Log In
Log In
Log In
Upgrade
Asia and Others
904.99B
Log In
Log In
Log In
Log In
Upgrade
Asia and Others Growth
13.26%
Log In
Log In
Log In
Log In
Upgrade